Annual D&A
$2.93 M
+$1.15 M+64.46%
31 December 2022
Summary:
Mirati Therapeutics annual depreciation & amortization is currently $2.93 million, with the most recent change of +$1.15 million (+64.46%) on 31 December 2022. During the last 3 years, it has risen by +$1.15 million (+64.46%).MRTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$1.11 M
+$8000.00+0.72%
30 September 2023
Summary:
Mirati Therapeutics quarterly depreciation & amortization is currently $1.11 million, with the most recent change of +$8000.00 (+0.72%) on 30 September 2023.MRTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$4.19 M
+$399.00 K+10.53%
30 September 2023
Summary:
Mirati Therapeutics TTM depreciation & amortization is currently $4.19 million, with the most recent change of +$399.00 thousand (+10.53%) on 30 September 2023.MRTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRTX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +64.5% | +98.4% | +135.2% |
| 5 y5 years | +1076.3% | +1098.9% | +1581.9% |
MRTX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | at high | at high | at high |
Mirati Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $1.11 M(+0.7%) | $4.19 M(+10.5%) |
| June 2023 | - | $1.11 M(+3.0%) | $3.79 M(+12.3%) |
| Mar 2023 | - | $1.07 M(+20.7%) | $3.38 M(+15.2%) |
| Dec 2022 | $2.93 M(+64.5%) | $891.00 K(+24.4%) | $2.93 M(+12.7%) |
| Sept 2022 | - | $716.00 K(+3.3%) | $2.60 M(+8.4%) |
| June 2022 | - | $693.00 K(+10.2%) | $2.40 M(+13.3%) |
| Mar 2022 | - | $629.00 K(+11.9%) | $2.12 M(+18.8%) |
| Dec 2021 | $1.78 M(+177.8%) | $562.00 K(+9.3%) | $1.78 M(+25.0%) |
| Sept 2021 | - | $514.00 K(+25.1%) | $1.43 M(+30.4%) |
| June 2021 | - | $411.00 K(+39.8%) | $1.09 M(+35.1%) |
| Mar 2021 | - | $294.00 K(+42.7%) | $809.00 K(+26.2%) |
| Dec 2020 | $641.00 K(+157.4%) | $206.00 K(+13.2%) | $641.00 K(+21.4%) |
| Sept 2020 | - | $182.00 K(+43.3%) | $528.00 K(+31.0%) |
| June 2020 | - | $127.00 K(+0.8%) | $403.00 K(+21.8%) |
| Mar 2020 | - | $126.00 K(+35.5%) | $331.00 K(+32.9%) |
| Dec 2019 | $249.00 K(+42.3%) | $93.00 K(+63.2%) | $249.00 K(+24.5%) |
| Sept 2019 | - | $57.00 K(+3.6%) | $200.00 K(+3.1%) |
| June 2019 | - | $55.00 K(+25.0%) | $194.00 K(+9.0%) |
| Mar 2019 | - | $44.00 K(0.0%) | $178.00 K(+1.7%) |
| Dec 2018 | $175.00 K(-4.9%) | $44.00 K(-13.7%) | $175.00 K(-1.1%) |
| Sept 2018 | - | $51.00 K(+30.8%) | $177.00 K(+2.3%) |
| June 2018 | - | $39.00 K(-4.9%) | $173.00 K(-3.9%) |
| Mar 2018 | - | $41.00 K(-10.9%) | $180.00 K(-2.2%) |
| Dec 2017 | $184.00 K(+2.2%) | $46.00 K(-2.1%) | $184.00 K(+2.8%) |
| Sept 2017 | - | $47.00 K(+2.2%) | $179.00 K(+5.3%) |
| June 2017 | - | $46.00 K(+2.2%) | $170.00 K(+1.8%) |
| Mar 2017 | - | $45.00 K(+9.8%) | $167.00 K(-7.2%) |
| Dec 2016 | $180.00 K(-15.1%) | $41.00 K(+7.9%) | $180.00 K(-9.1%) |
| Sept 2016 | - | $38.00 K(-11.6%) | $198.00 K(-7.0%) |
| June 2016 | - | $43.00 K(-25.9%) | $213.00 K(-5.8%) |
| Mar 2016 | - | $58.00 K(-1.7%) | $226.00 K(+6.6%) |
| Dec 2015 | $212.00 K(+6.5%) | $59.00 K(+11.3%) | $212.00 K(+7.1%) |
| Sept 2015 | - | $53.00 K(-5.4%) | $198.00 K(+8.2%) |
| June 2015 | - | $56.00 K(+27.3%) | $183.00 K(+10.9%) |
| Mar 2015 | - | $44.00 K(-2.2%) | $165.00 K(-17.1%) |
| Dec 2014 | $199.00 K | $45.00 K(+18.4%) | $199.00 K(-9.5%) |
| Sept 2014 | - | $38.00 K(0.0%) | $220.00 K(-1.3%) |
| June 2014 | - | $38.00 K(-51.3%) | $223.00 K(-1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $78.00 K(+18.2%) | $227.00 K(+32.7%) |
| Dec 2013 | $171.00 K(+39.0%) | $66.00 K(+61.0%) | $171.00 K(+31.5%) |
| Sept 2013 | - | $41.00 K(-2.4%) | $130.00 K(+9.2%) |
| June 2013 | - | $42.00 K(+90.9%) | $119.00 K(+6.3%) |
| Mar 2013 | - | $22.00 K(-12.0%) | $112.00 K(-8.9%) |
| Dec 2012 | $123.00 K(-35.3%) | $25.00 K(-16.7%) | $123.00 K(-6.0%) |
| Sept 2012 | - | $30.00 K(-14.3%) | $130.90 K(+10.4%) |
| June 2012 | - | $35.00 K(+6.1%) | $118.60 K(-7.6%) |
| Mar 2012 | - | $33.00 K(+0.3%) | $128.30 K(-32.5%) |
| Dec 2011 | $190.00 K(-73.0%) | $32.90 K(+85.9%) | $190.00 K(-38.6%) |
| Sept 2011 | - | $17.70 K(-60.4%) | $309.50 K(-32.0%) |
| June 2011 | - | $44.70 K(-52.8%) | $455.20 K(-21.2%) |
| Mar 2011 | - | $94.70 K(-37.9%) | $577.80 K(-17.8%) |
| Dec 2010 | $702.90 K(-26.1%) | $152.40 K(-6.7%) | $702.80 K(-11.3%) |
| Sept 2010 | - | $163.40 K(-2.3%) | $792.50 K(-11.2%) |
| June 2010 | - | $167.30 K(-23.9%) | $892.90 K(-7.1%) |
| Mar 2010 | - | $219.70 K(-9.3%) | $961.10 K(+1.0%) |
| Dec 2009 | $951.20 K(-1.1%) | $242.10 K(-8.2%) | $951.30 K(+29.9%) |
| Sept 2009 | - | $263.80 K(+12.0%) | $732.50 K(-1.5%) |
| June 2009 | - | $235.50 K(+12.2%) | $743.50 K(-11.1%) |
| Mar 2009 | - | $209.90 K(+800.9%) | $836.00 K(-13.0%) |
| Dec 2008 | $961.40 K(-34.9%) | $23.30 K(-91.5%) | $961.30 K(-25.8%) |
| Sept 2008 | - | $274.80 K(-16.2%) | $1.30 M(-9.3%) |
| June 2008 | - | $328.00 K(-2.1%) | $1.43 M(-3.3%) |
| Mar 2008 | - | $335.20 K(-6.4%) | $1.48 M(+0.1%) |
| Dec 2007 | $1.48 M(+15.2%) | $358.30 K(-12.0%) | $1.48 M(+2.7%) |
| Sept 2007 | - | $407.30 K(+8.0%) | $1.44 M(+5.4%) |
| June 2007 | - | $377.10 K(+13.0%) | $1.36 M(+3.6%) |
| Mar 2007 | - | $333.70 K(+4.5%) | $1.32 M(+2.7%) |
| Dec 2006 | $1.28 M(+16.8%) | $319.20 K(-4.4%) | $1.28 M(+3.1%) |
| Sept 2006 | - | $333.90 K(+1.2%) | $1.24 M(+1.6%) |
| June 2006 | - | $330.10 K(+10.6%) | $1.22 M(+6.7%) |
| Mar 2006 | - | $298.50 K(+6.4%) | $1.15 M(+4.5%) |
| Dec 2005 | $1.10 M(-13.9%) | $280.50 K(-10.8%) | $1.10 M(+34.3%) |
| Sept 2005 | - | $314.60 K(+24.3%) | $816.90 K(+62.6%) |
| June 2005 | - | $253.00 K(+1.5%) | $502.30 K(+101.5%) |
| Mar 2005 | - | $249.30 K | $249.30 K |
| Dec 2004 | $1.27 M(+54.1%) | - | - |
| Dec 2003 | $826.80 K | - | - |
FAQ
- What is Mirati Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Mirati Therapeutics?
- What is Mirati Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Mirati Therapeutics?
What is Mirati Therapeutics annual depreciation & amortization?
The current annual D&A of MRTX is $2.93 M
What is the all time high annual D&A for Mirati Therapeutics?
Mirati Therapeutics all-time high annual depreciation & amortization is $2.93 M
What is Mirati Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of MRTX is $1.11 M
What is the all time high quarterly D&A for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly depreciation & amortization is $1.11 M
What is Mirati Therapeutics TTM depreciation & amortization?
The current TTM D&A of MRTX is $4.19 M
What is the all time high TTM D&A for Mirati Therapeutics?
Mirati Therapeutics all-time high TTM depreciation & amortization is $4.19 M